At Lilly, we recognize that cardiometabolic conditions and risk factors exist along a continuum. That’s why we’re committed to a whole-person approach to care across the spectrum of #T2D management.
Lilly Diabetes International
Pharmaceutical Manufacturing
Channel for the Professional Diabetes Community. Follow us for useful Diabetes related info.
About us
Lilly unites caring with discovery to make life better for people around the world. When you engage with Lilly on LinkedIn (and any other of Lilly’s social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other legal notices provided by Lilly and those of LinkedIn.
- Website
-
https://e.lilly/3Rg4GSW
External link for Lilly Diabetes International
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
Updates
-
As #ADASciSessions concludes, the diabetes community’s commitment to improving #T2D outcomes shines through. Wrapping up our 'Daily Takeaways' series, Prof. Leszek Czupryniak distils key learnings from the event. Watch now to catch the complete #ADA2026 conference summary.
-
Early intervention in #T2D was a major focus at this year’s #ADASciSessions. Aligning with what leading experts are saying, Professor Tofé’s previous insights echo why proactive management is vital to supporting long-term outcomes and individualized care.
-
-
As #ADASciSessions comes to a close, thank you for following along and engaging in the discussions shaping the future of diabetes care. We look forward to continuing the conversation around #DiabetesCare going forward.
-
-
The final day of #ADASciSessions focused on closing the gap between clinical guidance and real-world #DiabetesCare. Watch Prof. Leszek Czupryniak discuss the key insights and learnings from yesterday's sessions.
-
How important is early intervention in #T2D care? This was the key theme of Day 3 at #ADASciSessions. Explore the takeaways from this day of the conference with Prof. Leszek Czupryniak in this video from the 'Daily Takeaways' series. Follow for more updates from #ADA2026.
-
As conversations continue at #ADASciSessions, the topic of therapeutic inertia remains closely tied to long-term challenges in #DiabetesCare. How can earlier, proactive management help shape a better future?
-
Day 2 of #ADASciSessions focused on a holistic approach to #T2D care, with a spotlight on metabolic health. Prof. Leszek Czupryniak shares his takeaways from sessions he attended below. Keep an eye out for more videos from our 'Daily Takeaways' series!
-
We are halfway through #ADASciSessions! Lilly is partnering with Prof. Leszek Czupryniak to dive into the links between #T2D, weight, and metabolic health as part of our 'Daily Takeaways' video series. Keep an eye out to catch key insights from #ADA2026.
-
-
Excess adiposity may contribute to the progression of obesity-related complications, including #T2D. Could earlier intervention help address this progression? Join our Diabetes Learning Byte talk at #ADASciSessions to learn more.
-